Gamma Research analysis shows that special immune cells called gamma-delta 17 cells drive scarring around medical implants by communicating with scar-tissue-producing cells, and this process worsens with age and high-fat diets. A 2026 study in Nature Communications found that these immune cells persist at implant sites and produce chemical signals that increase collagen production and abnormal blood vessel growth, suggesting future implants might be designed to control these cells and reduce scarring.
When doctors place medical devices like pacemakers or joint replacements in your body, your immune system responds by creating scar tissue around the implant. A new study from Nature Communications reveals that special immune cells called gamma-delta T cells play a surprising role in controlling how much scar tissue forms and how blood vessels develop around the implant. Researchers found that these immune cells communicate with other cells in your body to either increase or decrease scarring, and this process gets worse with age and unhealthy diets. Understanding this process could help doctors develop better implants that don’t trigger excessive scarring.
Key Statistics
A 2026 study published in Nature Communications found that gamma-delta 17 immune cells persist at implant sites and become the dominant producers of interleukin-17, a chemical messenger that drives scar tissue formation around medical devices.
Research shows that the gamma-delta 17 cell compartment expands significantly in older mice and mice fed high-fat diets, both conditions associated with chronic inflammation and excessive fibrosis around implants.
When fibroblasts were co-cultured with gamma-delta 17 cells in laboratory studies, collagen gene expression increased substantially, demonstrating direct communication between immune cells and scar-tissue-producing cells.
Mice genetically lacking gamma-delta T cells showed altered extracellular matrix composition and increased blood vessel size within fibrotic tissue, indicating these immune cells regulate both the quantity and quality of scar tissue formation.
The Quick Take
- What they studied: How special immune cells called gamma-delta T cells influence scarring and blood vessel growth around medical implants placed in the body
- Who participated: Laboratory mice with implanted biomaterials, with additional studies examining how aging and high-fat diets affected the immune response
- Key finding: Gamma-delta T cells, particularly a type called gamma-delta 17 cells, persist around implants and drive the production of scar tissue by communicating with fibroblasts and blood vessel cells
- What it means for you: Future medical implants might be designed to reduce scarring by controlling these immune cells, potentially improving outcomes for people with pacemakers, artificial joints, and other implanted devices. However, this research is still in early stages and hasn’t been tested in humans yet
The Research Details
Researchers used mice with implanted biomaterials to observe what happens when the immune system responds to foreign objects in the body. They tracked different types of gamma-delta T cells over time to see how they changed as scarring developed. The team also studied how these immune cells communicate with fibroblasts (cells that make scar tissue) and endothelial cells (cells that form blood vessels) by growing them together in laboratory dishes.
To understand the full picture, the researchers examined how aging and high-fat diets affected this immune response, since both are known to increase inflammation and scarring in the body. Finally, they used genetically modified mice without gamma-delta T cells to see what changed when these immune cells were completely absent.
This research approach is important because it shows how different parts of your immune system work together with other body cells to create scarring. Rather than looking at just one piece of the puzzle, the researchers examined the entire conversation between immune cells and tissue-building cells. This helps explain why some people develop excessive scarring around implants while others don’t, and why age and diet seem to make scarring worse.
This study was published in Nature Communications, a highly respected scientific journal. The researchers used multiple approaches to confirm their findings, including laboratory cell cultures and living animal models. However, because this work was done in mice rather than humans, the results may not directly apply to people. The study also doesn’t specify the exact number of mice used, which makes it harder to assess the statistical power of the findings.
What the Results Show
The research shows that two different types of gamma-delta T cells arrive at implant sites during the initial immune response. One type, called gamma-delta IFNγ cells, decreases over time as scarring develops. The other type, gamma-delta 17 cells, actually increases and becomes the dominant immune cell producing a chemical messenger called interleukin-17.
When researchers grew fibroblasts (scar-tissue-making cells) together with gamma-delta 17 cells in the laboratory, the fibroblasts produced significantly more collagen—the main protein in scar tissue. This suggests that gamma-delta 17 cells directly stimulate scar formation. The communication between these cells involves specific molecular signals that activate programs in fibroblasts and blood vessel cells that promote both scar tissue production and abnormal blood vessel growth.
Interestingly, the gamma-delta 17 cell compartment expanded in older mice and in mice fed high-fat diets, both conditions associated with chronic inflammation. This suggests that age and poor diet may increase scarring risk by boosting these problematic immune cells.
When researchers deleted gamma-delta T cells entirely from mice, the composition of scar tissue changed and blood vessels within the scar tissue became larger than normal. This indicates that these immune cells don’t just increase scarring—they also control the quality and structure of the scar tissue that forms. The findings suggest that gamma-delta T cells help regulate how organized and functional the scar tissue becomes.
Previous research has shown that immune cells influence scarring, but this study provides new detail about which specific immune cells matter most and how they communicate with other cells. Most prior work focused on other immune cell types like T helper cells. This research highlights gamma-delta T cells as previously underappreciated players in controlling fibrosis around implants. The findings align with growing evidence that aging and high-fat diets promote chronic inflammation and excessive scarring throughout the body.
This study was conducted entirely in mice, so results may not directly translate to humans. The research doesn’t specify how many mice were used, making it difficult to assess statistical reliability. The study focused on one type of biomaterial implant, so results might differ with other implant types. Additionally, the research was conducted in laboratory conditions that may not fully replicate the complexity of the human body. Long-term studies in humans would be needed to confirm whether controlling these immune cells could actually reduce scarring around medical devices.
The Bottom Line
Based on this research, maintaining a healthy diet and managing age-related inflammation may help reduce excessive scarring around medical implants, though this hasn’t been proven in humans yet. Doctors might eventually develop treatments that target gamma-delta 17 cells to prevent problematic scarring. However, these recommendations are preliminary and based on animal studies. Anyone with medical implants should follow their doctor’s standard care instructions and discuss any concerns about scarring or implant function.
This research is most relevant to people who have or will receive medical implants like pacemakers, artificial joints, or other devices. It’s also important for people with conditions involving excessive scarring. Researchers and medical device companies should care about these findings as they develop better implants. However, this is basic science research, so practical applications for patients are likely years away.
This research is in early stages and hasn’t been tested in humans. If researchers pursue treatments based on these findings, it would likely take 5-10 years or more before any new therapies become available to patients. In the meantime, people with implants should focus on proven strategies like maintaining a healthy diet, regular exercise, and following post-implant care instructions.
Frequently Asked Questions
What causes excessive scarring around medical implants?
Excessive scarring around implants results from immune cells called gamma-delta 17 cells communicating with fibroblasts to increase collagen production. This process is amplified by aging and high-fat diets, both of which expand the gamma-delta 17 cell population and increase chronic inflammation.
Can diet affect how much scarring develops around implants?
According to research reviewed by Gram, high-fat diets expand the immune cells that drive scarring around implants. Maintaining a healthy diet may help reduce this problematic immune response, though this hasn’t been proven in humans yet.
How do immune cells communicate with scar tissue cells?
Gamma-delta T cells produce chemical signals like interleukin-17 that activate fibroblasts and blood vessel cells, triggering them to produce more collagen and form abnormal blood vessels. This cell-to-cell communication drives both excessive scarring and abnormal tissue structure.
Could controlling these immune cells reduce implant scarring?
Potentially, yes. Mice without gamma-delta T cells showed altered scar tissue composition and different blood vessel patterns, suggesting that targeting these immune cells could reduce problematic scarring. However, this approach hasn’t been tested in humans and would require years of development.
Does age affect how much scarring happens around implants?
Yes. Research shows that the gamma-delta 17 cell compartment expands with aging, and these cells drive scar tissue formation. This explains why older individuals may experience more scarring around implants compared to younger people.
Want to Apply This Research?
- Track inflammation markers by monitoring symptoms like redness, warmth, or swelling around implant sites weekly, and log diet quality (servings of vegetables, processed foods, added sugars) to correlate with any changes in implant-related symptoms
- Use the app to set reminders for anti-inflammatory eating habits (Mediterranean diet patterns) and track physical activity, since research suggests these may help reduce the immune response that drives scarring around implants
- Create a long-term log of implant-related symptoms and health markers, comparing periods of healthy eating and exercise to periods of poor diet and inactivity, to identify personal patterns in inflammation and scarring progression
This research is based on studies in mice and has not been tested in humans. The findings represent early-stage basic science research. Anyone with medical implants should follow their physician’s care instructions and discuss concerns about scarring or implant function with their healthcare provider. This article is for informational purposes only and should not be used to make medical decisions or replace professional medical advice. Future treatments based on this research are likely years away from clinical availability.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.